NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
Go back to NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy| (NASDAQ: AKRO) | Delayed: 54.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.74 | 52 Week High | $ | |||
| Open | $54.74 | 52 Week Low | $ | |||
| Day High | $54.74 | P/E | N/A | |||
| Day Low | $54.74 | EPS | $ | |||
| Volume | 746 | |||||
| (NASDAQ: NXTC) | Delayed: 7.82 -0.02 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.84 | 52 Week High | $ | |||
| Open | $7.79 | 52 Week Low | $ | |||
| Day High | $8.23 | P/E | N/A | |||
| Day Low | $7.57 | EPS | $ | |||
| Volume | 60,632 | |||||
